Clinical trial Recruiting at 1 site Observational Ages 7 to 17

Comparing different methods for correcting myopia in youth

Official title: A Comparative Study on the Clinical Efficacy, Quality of Life, and Cost of Use of Peripheral Defocus Spectacles, Frame Glasses, and Orthokeratology Lenses in Myopic Children and Adolescents

Run by He Eye Hospital · NCT06278974 · Data updated 2026-11-12

This study tests which of three methods for correcting nearsightedness—special glasses, regular glasses, or contact lenses worn overnight—works best for kids aged 13 to 17 and how it affects their daily lives.

Quick facts

Study typeObservational
Ages7 Years to 17 Years
SexAll
Enrollment90 (estimated)
SponsorHe Eye Hospital
Academic / other
Locations1 site (Shenyang, Liaoning)
StatusRecruiting
StartedNovember 10, 2023
Main results expectedMay 1, 2027
Study endsJuly 1, 2027
Registry record updatedMarch 23, 2026
Trial IDNCT06278974 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 13-17 years with myopia between -1.00D and -6.00D who have not previously used any of the correction methods being studied.

Probably not a fit

Patients with other eye conditions, recent eye surgeries, or severe psychological disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research evaluates the effectiveness, quality of life impact, and cost of three myopia correction methods in children aged 13-17 years: peripheral defocus spectacles, standard frame glasses, and orthokeratology lenses. The study involves a cohort of 300 myopic children with a refractive error between -1.00D and -6.00D, assessing their psychological, social, and educational experiences over one year. By comparing these methods, the study aims to provide valuable insights for parents and healthcare providers in choosing the most suitable correction options for young patients.

Why it matters

Potential benefit: If successful, this study could help identify the most effective and cost-efficient myopia correction method, improving the quality of life for affected youth.

How similar studies have gone: While there have been studies on myopia correction methods, this specific comparative approach focusing on quality of life and cost-effectiveness is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Children aged 7-17 years.
* Myopia between -1.00D and -6.00D; astigmatism \<±1.5D; best corrected visual acuity ≥1.0.
* First-time spectacle wearers who use a single correction method and meet the indications for it (any one of orthokeratology lenses, single-vision frame glasses, or myopia control frame glasses)
* Willing to participate in the entire research process and complete all the examinations, questionnaires and cost records as required.
* Be able to maintain contact throughout the research period, such as having a fixed address and contact information.

Exclusion Criteria:

* History of strabismus, amblyopia, refractive disparity or retinal diseases
* Previous history of eye surgery
* Severe psychological disorders or behavioral problems
* History of allergy to contact lenses or contact lens care solutions

Where it's running

  • HeEyeHospital
    Shenyang, Liaoning, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.